🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSingapore HSA regulations — 12 month update Page 6

Singapore HSA regulations — 12 month update

quinn_sf Wed, Sep 11, 2024 at 1:49 PM 36 replies 2,367 viewsPage 6 of 8
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Oct 14, 2024 at 2:36 PM#26
FDA_TrackerJim said:
Practical: whatever you change, write down the date and the reason.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

45 20adam_van, Dr.SurgeonPGH, rachel_ABQ and 42 others
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Oct 18, 2024 at 9:37 PM#27
FDA_TrackerJim said:
Practical: whatever you change, write down the date and the reason.

Bookmarking. The distinction being drawn above is the one nobody else makes. Printing the relevant bit and taking it with me.

44 19Dr.ObesityLA, NurseKim_ATL, paul_denver and 41 others
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Oct 23, 2024 at 4:40 AM#28

Adding the clinical framing, because it changes how the question reads. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

43 18tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 40 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Oct 27, 2024 at 11:46 AM#29
Dr.CardioMD said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Same experience, arrived at from the opposite direction. The detail I would add is minor and it is already implied above.

Last edited: Oct 27, 2024 at 4:46 PM
42 17anders_CPH, Dr.NutriCornell, pam_stl and 39 others
Reply Quote Save Share Report
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Oct 31, 2024 at 6:54 PM#30

Reporting back.

Coming back a few months on. It held. Nothing dramatic to report, which is the report.

20 20Dr.EndoEP, GraceAZ_72, carl_compliance and 17 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register